Next Article in Journal
Clinical Pharmacology Packages of FDA-Approved Biologic License Applications in Oncology from 2015 to 2025
Previous Article in Journal
Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310
 
 
Retraction

Article Versions Notes

Drugs Drug Candidates 2026, 5(1), 3; https://doi.org/10.3390/ddc5010003
Action Date Notes Link
article html file updated 31 December 2025 02:42 CET Original file https://www.mdpi.com/2813-2998/5/1/3/html
article pdf uploaded. 31 December 2025 02:40 CET Version of Record https://www.mdpi.com/2813-2998/5/1/3/pdf
article xml uploaded. 31 December 2025 02:40 CET Update https://www.mdpi.com/2813-2998/5/1/3/xml
article xml file uploaded 31 December 2025 02:40 CET Original file -
Back to TopTop